Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease

Journal of the National Cancer Institute

Volumn 89, Issue 18, 1997, Pages 1356-1360

  Cheng, Liang ^a   Al Kaisi, Nadia K ^a   Gordon, Nahida H ^a   Liu, Alison Y ^a   Gebrail, Fadi ^a   Shenk, Robert R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SIZE; CARCINOMA IN SITU; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; TREATMENT OUTCOME;

EID: 0030824090     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.18.1356     Document Type: Article

References (25)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-8.
2. Frykberg ER, Bland KI. Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 1994;74(1 Suppl): 350-61.
3. Morrow M, Schmidt R, Cregger B, Hassett C, Cox S. Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsy. Arch Surg 1994;129:1091-6.
4. Meyer JE, Eberlein TI, Stomper PC, Sonnenfeld MR. Biopsy of occult breast lesions. Analysis of 1261 abnormalities. JAMA 1990; 263:2341-3.
5. Simpson T, Thirlby RC, Dail DH. Surgical treatment of ductal carcinoma in situ of the breast: 10-to 20-year follow-up. Arch Surg 1992;127:468-72.
6. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31A:1425-7.
7. Silverstein MJ, Cohlan BF, Gierson ED, Furmanski M. Gamagami P, Colburn WJ, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992;28: 630-4.
8. Betsill WL Jr, Rosen PP, Lieberman PH, Robbins GF. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 1978;239:1863-7.
9. Lagios MD. Heterogeneity of ductal carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation. Cancer Lett 1995;90: 97-102.
10. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995;76:259-67.
11. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74: 1746-51.
12. Spivack B, Khanna MM, Tafra L, Juillard G, Giuliano AE. Margin status and local recurrence after breast-conserving surgery. Arch Surg 1994;129:952-7.
13. Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993;218:22-8.
14. Schmidt-Ullrich R, Wazer DE, Tercilla O, Safaii H, Marchant DJ, Smith TJ, et al. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int Radiat Oncol Bio Phys 1989;17:733-8.
15. Frazier TG, Wong RW, Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg 1989;124: 37-8.
16. Cataliotti L, Distante V, Ciatto S, Bianchi S, Pacini P, Simoncini R, et al. Intraductal breast cancer: review of 183 consecutive cases. Eur J Cancer 1992;28A:917-20.
17. Page DL, Jensen RA. Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild [editorial]. JAMA 1996;275:948-9.
18. Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988;318:898-903.
19. Morrow M. The natural history of ductal carcinoma in situ. Implications for clinical decision making [editorial]. Cancer 1995;76:1113-5.
20. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76: 1197-200.
21. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 1994; 73:118-24.
22. Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-8.
23. Silverstein MJ, Gierson ED, Colburn WJ, Cope LM, Furmanski M, Senofsky GM, et al. Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 1994;73: 2985-9.
24. Sneige N, McNeese MD, Atkinson EN, Ames FC, Kemp B, Sahin A, et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: histolopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol 1995;26:642-9.
25. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-7.